Intel Corporation (NASDAQ:INTC) saw its shares slip 1.97% to $102.50 on Friday, ending a three-day winning streak. Despite the pullback, the stock closed comfortably above the $95 per-share price from the company's recently expanded equity offering, preserving a 7.9% premium. The price action suggests that investors absorbed the larger-than-expected capital raise without immediately discounting the stock to the offering level.
Expanded Offering and Dilution
The semiconductor giant raised $20 billion through its share sale, up from the original $15 billion target—a 33% increase. At the $95 offering price, this translates to roughly 210.5 million new shares, representing about 4.2% dilution based on Friday's market capitalization of $517 billion. The market's acceptance of the additional supply is notable, especially given the size of the increase.
Capital Expenditure and Growth Plans
The proceeds are earmarked for Intel's aggressive manufacturing expansion. The company raised its 2026 capital expenditure outlook to over $20 billion, up from $18 billion, with further increases expected in 2027 as it scales 18A production and advanced packaging operations. This investment is underpinned by strong demand: second-quarter revenue jumped 25% year-over-year to $16.1 billion, with Data Center and AI revenue surging 59% to $6.3 billion. Adjusted gross margin improved to 41.8%, up from 29.7% a year earlier.
CEO Lip-Bu Tan highlighted the AI-driven demand, calling it the company's best revenue growth period in over 15 years. However, the headline GAAP net loss of $11 billion includes a $12.5 billion mark-to-market charge related to escrowed shares tied to the U.S. CHIPS Act agreement. On an adjusted basis, Intel earned $2.2 billion.
Market Reaction and Analyst Divergence
Friday's trading was orderly, with volume of 94.3 million shares, about 23% below the 50-day average. The stock remains 28% below its June 30 peak of $142.35. Among peers, Intel lagged the broader market, while Qualcomm (NASDAQ:QCOM) gained 0.61% and Broadcom (NASDAQ:AVGO) fell 5.94%.
Analyst opinions on Intel's turnaround are sharply divided. KeyBanc maintains an Overweight rating with a $155 price target, implying 51% upside from Friday's close. In contrast, Rosenblatt has a Sell rating with an $80 target, suggesting a 22% decline. The $75 spread between these targets is equivalent to 73% of the stock's current value, reflecting uncertainty about the foundry strategy's execution and customer adoption.
Risks and Watch Items
The offering dilutes existing shareholders, and foundry execution risks remain. Increased factory investment could strain cash reserves if external clients delay orders. A drop below $95 would signal that the market no longer views the offering price as a support level. Investors will watch for additional 14A customer announcements and trading volume to gauge whether the share supply is being absorbed at current prices.
Intel's strategic bet on AI and advanced manufacturing is bold, but the wide analyst range highlights the high stakes. The coming weeks will be crucial in determining whether the company can sustain momentum and justify its valuation.
